✦ LIBER ✦

Nephrotoxicity: A comparison in humans of gentamicin and gentamicin C1 administration

✍ Scribed by Arden W. Forrey; B.Teri Meijsen-Ludwick; Michelle A. O'Neill; Barbara M. Maxwell; Andrew D. Blair; Ralph E. Cutler

Book ID: 116072328
Publisher: Elsevier Science
Year: 1978
Tongue: English
Weight: 590 KB
Volume: 44
Category: Article
ISSN: 0041-008X
DOI: 10.1016/0041-008x(78)90253-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Diltiazem Enhances Gentamicin Nephrotoxi

Diltiazem Enhances Gentamicin Nephrotoxicity in Rats

✍ Gomez, A. ;Martos, F. ;Garcia, R. ;Perez, B. ;Cuesta, F. Sanchez 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB

Gentamicin Nephrotoxicity – A Comparison

Gentamicin Nephrotoxicity – A Comparison ofIn VitroFindings withIn VivoExperiments in Equines

✍ M.R. van der Harst; S. Bull; C.M. Laffont; W.R. Klein 📂 Article 📅 2005 🏛 Springer Netherlands 🌐 English ⚖ 332 KB

Gentamicin Nephrotoxicity in Rat: Some B

Gentamicin Nephrotoxicity in Rat: Some Biochemical Correlates

✍ Ali, B. H. ;Gayoum, A. A. Abdel ;Bashir, A. A. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

Comparison of gentamicin C1and (C1a, C2)

Comparison of gentamicin C1and (C1a, C2)-levels in patients

✍ Roger L. Nation; Geoffrey W. Peng; Win L. Chiou; James Malow 📂 Article 📅 1978 🏛 Springer 🌐 English ⚖ 421 KB

Protective effect of chelerythrine on ge

Protective effect of chelerythrine on gentamicin-induced nephrotoxicity

✍ H. Parlakpinar; S. Tasdemir; A. Polat; A. Bay-Karabulut; N. Vardi; M. Ucar; M. Y 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 371 KB 👁 1 views

Comparison of gentamicin and tobramycin

Comparison of gentamicin and tobramycin nephrotoxicity in patients receiving individualized-pharmacokinetic dosing regimens

✍ Salvador Pancorbo; Christina Compty; Joseph Heissler 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

## Abstract The incidence of nephrotoxicity has been studied in 175 patients who received either gentamicin or tobramycin. All patients received individualized dosing regimens of the drugs based on pharmacokinetic parameters measured after the initial dose. Subsequent doses were calculated from the